MRK trades 11.6% below analyst target after revenue beat
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Analysts have given Merck & Co., Inc. (NYSE:MRK) a "Moderate Buy" consensus rating with an average 12-month price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context